Points of View on Lindane
Centers for Disease Control and Prevention
The Centers for Disease Control and Prevention (CDC) helps to set practice standards for the medical community. The CDC currently includes lindane in its Sexually Transmitted Disease (STD) Treatment Guidelines for the management of scabies. These recommendations are based on a thorough and systematic review of available evidence on the safety and effectiveness of lindane medications by healthcare experts.
CDC includes lindane in its STD treatment guidelines for scabies
The CDC is one of 13 major operating components of the Department of Health and Human Services and is dedicated to the prevention and control of infectious and chronic diseases. The CDC consults with subject matter experts to develop treatment guidelines and set practice standards for the healthcare community.
Current CDC Guidelines for Scabies
- 2010 CDC STD Treatment Guidelines:1
CDC designates lindane as an alternative regimen for treating scabies.
The CDC further notes that lindane should not be used immediately after a bath or shower, and it should not be used by persons who have extensive dermatitis, women who are pregnant or lactating or children aged <2 years. (2010 CDC STD Treatment Guidelines for scabies)
For additional information about the CDC’s viewpoint on lindane, please visit http://www.cdc.gov/std/treatment/.
Please See Important Safety Information on Lindane
- U.S. Centers for Disease Control and Prevention (CDC). Ectoparasitic infections. Sexually transmitted diseases treatment guidelines. 2010. MMWR Recomm Rep. 2010, December 17;59 (No. RR-12):79-80. Web version available at: http://www.cdc.gov/std/treatment.